Friday May 24, 2019 Change 2.24% Price $65.36
Chart period: 2019-02-25 - 2019-05-24




Will TNDM stock price go up or down on Tue, 28 May 2019?


Tandem Diabetes Care Forecast and Stock Analysis

Technical TNDM stock analysis for Friday May 24, 2019.

Hold candidate since 2019-05-24
Shorts n/a
Insider % n/a
Institutional % n/a
Beta 2.42
ROA -62.83%
Price to book USD 32.15
P/E Ratio -30.84
Next Earnings Date 2019-07-28

Tandem Diabetes Care gained 2.24% in the last trading day ( Friday, 24th May 2019 ), rising from $63.93 to $65.36 During day the stock fluctuated 2.46% from a day low at $64.30 to a day high of $65.88. The price has been going up and down for this period, and there has been a 1.15% gain for the last 2 weeks. Volume fell in the last day by -775 276 shares, and in total, 642 948 shares bought and sold for approximately $42.02 million. You should take into consideration that a falling volume on higher prices causes divergence and may be an early warning about possible changes for the next couple of days.

Quick summary:

  • 30 day high of the TNDM stock price was $72.04 and low was $56.68.
  • 90 day high was $74.81 and low was $47.36.
  • 52 week high for the Tandem Diabetes Care - $74.81 and low - $11.62.


Given the current horizontal trend you can expect Tandem Diabetes Care with 90% probability to be traded between $54.31 and $73.41 at the end of this period with 90% probability. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the roof. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Click here for today's Top 5 Trending Companies


Tandem Diabetes Care holds a sales signal from the short-term moving average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock. On further gains, the stock will meet resistance from the short-term moving average at approximately $66.73. On a fall, the stock will find some support from the long-term average at approximately $63.35. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sales signal. A buy signal was issued from a pivot bottom point on Thursday May 23, 2019, which indicates further gains until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and may be an early warning. The stock should be watched closely.

Access today's Top 5 Golden Star Companies

Relative Strength Index (RSI)

RSI14 is 46 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Tandem Diabetes Care finds support from accumulated volume at $64.47.

Support: $64.47 Price: $65.36 Resistance: $65.57


This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.58 between high and low, or 2.46%. For the last week, the stock has had a daily average volatility of 3.37%.

Our recommended stoploss: $61.97 (-5.18%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 1 days ago.)

3.37 %

Average volatility

Overall risk:

Very Low Low Medium High Very High


Tandem Diabetes Care holds several positive signals, but we still don't find these to be enough for a buy-recommendation. At the current level we recommend to hold or accumulate in this position whilst awaiting for further development. We have upgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Hold/Accumulate.

Hold/Accumulate Upgraded
Previous Hold Today TNDM ranks #303 as HOLD CANDIDATE #303 Next Hold
TNDM $65.36 ($1.43 2.24%)
TNDM is up $1.43 today, but where's it headed in 2019?
Zacks Investment Research is releasing its prediction for TNDM based on the 1-3 month system that more than doubles the S&P 500.

This report is free today for readers.

Click here – the TNDM analysis is free »

Will TNDM stock price go up or down
on Tue, 28 May 2019?


Proudly made at

Rise Vilnius
in partnership with
Barclays Bank